UnitedHealth Group Redeemable noncontrolling interests in subsidiaries decreased by 62.8% to $1.61B in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates a higher potential future cash outflow obligation to minority shareholders, which may impact liquidity.
This represents the portion of equity in a subsidiary that is attributable to noncontrolling interests, which is subject...
Found in companies with complex organizational structures or joint venture arrangements; peers with significant M&A activity often carry these balances.
other_redeemable_noncontrolling_interest_equity_carrying_amount| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $4.32B | $1.61B |
| QoQ Change | — | -62.8% |
| YoY Change | — | -62.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.